Jun 27 |
What Makes Cybin Inc. (CYBN) a New Buy Stock
|
Jun 26 |
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
|
Jun 19 |
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
Jun 11 |
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround
|
Jun 11 |
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
|
May 29 |
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
|
May 6 |
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
|
Apr 29 |
Psychedelic drug developers could benefit from NIH funding for chronic pain
|
Apr 25 |
Cybin to Participate at the 27th Annual Milken Institute Global Conference
|
Apr 18 |
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
|